---
document_datetime: 2023-09-21 20:14:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/emtricitabinetenofovir-disoproxil-krka-dd-epar-all-authorised-presentations_en.pdf
document_name: emtricitabinetenofovir-disoproxil-krka-dd-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8768863
conversion_datetime: 2025-12-30 00:39:22.730842
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name                               | Strength        | Pharmaceutical Form   | Route of Administration   | Immediate Packaging           | Pack size                 |
|------------------|-----------------------------------------------|-----------------|-----------------------|---------------------------|-------------------------------|---------------------------|
| EU/1/17/1182/001 | Emtricitabine/Teno fovir disoproxil Krka d.d. | 200 mg / 245 mg | Film-coated tablet    | Oral use                  | blister (OPA/alu/PE+DE S/alu) | 28 x 1 tablet (unit dose) |
| EU/1/17/1182/002 | Emtricitabine/Teno fovir disoproxil Krka d.d. | 200 mg / 245 mg | Film-coated tablet    | Oral use                  | bottle (HDPE)                 | 30 tablets                |
| EU/1/17/1182/003 | Emtricitabine/Teno fovir disoproxil Krka d.d. | 200 mg / 245 mg | Film-coated tablet    | Oral use                  | blister (OPA/alu/PE+DE S/alu) | 84 tablets                |
| EU/1/17/1182/004 | Emtricitabine/Teno fovir disoproxil Krka d.d. | 200 mg / 245 mg | Film-coated tablet    | Oral use                  | bottle (HDPE)                 | 90 (3 x 30) tablets       |